YHM-17554-61587
2 vaccinations
2 coded responses
3 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 980 / WA
- Registered
- 2021-06-14
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-03
Dose 1 — Pfizer-BioNTech
-
2021-04-20
Dose 2 — Pfizer-BioNTech
-
2021-06-14
Registered in v-safe
-
2021-07-20
Survey response — 3 months, dose 2MedDRA: Cough, Dyspnoea, Headache, Nasal congestion, Oropharyngeal pain, Pyrexia, Respiratory tract infection viral, Rhinorrhoea, SARS-CoV-2 test negative, Sneezing — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Repiratory virus (not covid) - sneezing, runny/stuffy nose, sore throat, fever, headache, cough, trouble breathing. Tested neg for covid twice.MedDRA releases: 2024-11 · check-in free text available
-
2021-10-19
Survey response — 6 months, dose 2MedDRA: Gestational diabetes — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Gestational diabetesMedDRA releases: 2024-11 · check-in free text available
-
2021-10-19
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2021-10-22
- 2022-04-20
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-03 | Pfizer-BioNTech | |
| 2 | 2021-04-20 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-10-19 | Unsuccessful |
Free text
Release 9 — 3 months, dose 2
Symptoms: Repiratory virus (not covid) - sneezing, runny/stuffy nose, sore throat, fever, headache, cough, trouble breathing. Tested neg for covid twice.
Release 10 — 6 months, dose 2
Symptoms: Gestational diabetes
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Gestational diabetes | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory tract infection viral | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Sneezing | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release